Cancer and complexity
Our oldest description of cancer was discovered in Egypt and dates back to 3000 BC.
Breast cancer was described in the Edwyn Smith Papyrus with a written verdict:
"There is no treatment" [1] . Much of the anatomical and clinical knowledge obtained in the 16 th and 17 th centuries was followed by progress in pathology and experimental research in cancer treatment and scientific surgery in the 18 th and 19 th centuries. Today cancer still constitutes a major scientific endeavour occupying chemists, biologist, geneticists and physicists [101] . Cancers have been found in everything from coral to budgerigars and dinosaurs [102] . Despite at least 3 013 022 publications on cancer (1818-2014) and large-scale "omics" studies for humanity, cancer is still the "Emperor of all maladies" [2] . Although mortality levels are lower than for infectious/parasitic and heart disease [103] , cancer remains a fascinating scientific challenge, fundamentally due to its fearsome complexity.
A major complexity problem in cancer is occasioned by the fact that heterogeneity is a ubiquitous feature of tumors. Carcinogenesis is not a single step process and initiation through proliferation and metastasis stages are thought to be dynamically influenced by accumulation of a large number of genetic mutations [3] . Each round of cell division may cause increased instability and complexity of the genome that enhance tumor progress [3] . The enigmatic heterogeneity within the same kind of tumor makes manifestation of the disease unpredictable and greatly complicates clinical diagnosis via characteristics such as morphological features, cellular biomarkers, hormonal receptors, gene expression, propensity to metastasize and recurrence potentials [4, 5] . It has been suggested that cancer should be regarded as a chaotic process [6] and there is some recent evidence for stochastic changes in breast cancer cell lines [7] . Although progress is being made, advances in effective disease diagnosis, management and prognosis would be achieved by further understanding of the basis of this heterogeneity.
In the age of large-scale "omics" that followed on the completion of human genome sequencing, the development of ever more powerful DNA sequencing methods, of DNA-microarray technology and of proteomics led to two major large-scale methods for investigation of breast cancer and other diseases: (1) large-scale genome-wideassociation-strategies (GWAS) that involve screening of large number of patients to identify genetic mutations correlated with disease [8, 9] , and (2) extensive investigation of differential gene expression via transcriptomics and proteomics [10] .
The large-scale GWAS strategies have been found to have limitations, e.g. in complex diseases many common disease-correlated mutations are neither necessary nor sufficient for the disease and often seem only to be deleterious in the context of the genome/proteome of an individual [11] . This has led to proposals that such data needs to be integrated with transcriptomic, proteomic, metabolomic and clinical information to develop 'functional-network-based' conceptual models of normal function, disease, diagnostics and therapy [12, 13] . Large-scale screening of mRNA levels showed that multiple and extensive changes in mRNA levels are commonly seen in breast cancer [14] [15] [16] [17] . More recently such studies have been extended to involvement of micro-RNAs [18] and epigenetic modulation of chromatin [19] .
There were important reasons [20] to complement this work with high throughput proteomics methods, including that protein abundance may be different than transcript abundance and that for genetic variation, translation and protein stability may be more determinant for protein abundance than transcript levels [21] . Recent work on tumor samples suggests that transcriptomics and proteomics measurements of total abundance monitor different aspects of cancer cell function and provide highly complementary information [22] .
These methods are accompanied by very large numbers of more conventional but increasingly powerful molecular and cell biology studies that focus on specific local features within highly complex cellular networks and which are collected and collated in data bases such as GO, REACTOME, etc. For example, cancer-related eukaryotic cell proliferation is known to involve complex molecular choreography of mitogens that stimulate cell growth, membrane receptors, their signaling pathways, and downstream effectors of cell division and cellular metabolic state [15, 23, 24] .
Very complex cellular signalling systems modulate cancer cell function through post-translational modifications such as phosphorylation [25] and methylation/acetylation [26] . Large-scale proteomics detection of PTMs like phosphorylation or acetylation has been crucial in this area [27] .
A key feature long known from molecular and cell biology, but so far often ignored in many large-scale studies, is that cellular function is highly dependent on the spatial distribution of many cellular components, ranging over metabolites, low molecular weight signaling molecules (e.g. GTP, Ca 2+ , NADH, ROS), proteins, lipids, tRNA [28] , etc. An emerging theme, that is the focus of this report, is that the subcellular distribution of proteins is dynamic and context-dependent, that proteins may have different functions at different subcellular locations, that the dynamic distributions are a crucial feature of cellular function and that perturbation of spatial control may be an important feature of cancer. Indeed, we suggest that dynamic alterations of subcellular spatial distribution of proteins is at least equally important to changes in total protein abundance in cellular function.
Indications for the importance of dynamic subcellular distribution of proteins.
There are innumerable conventional cell biology studies that demonstrate functionally relevant subcellular translocation of specific individual proteins, even for proteins that were once regarded as "housekeeping" proteins [29] [30] [31] . The different subcellular translocation of the isoforms of hexokinases, HKI and HKII, is known to be a mechanism of cellular regulation addressing the cell to catabolic or anabolic glucose utilization both in proliferating cells or in cancer cells [32] . Two isoforms of pyruvate kinases, PKM1 and PKM2, have diverse involvement in metabolic pathways. These include the shuttling of pyruvate preferentially to lactate dehydrogenase instead of to mitochondria that underlines the major role of the cytoplasmic PKM2 isoform in tumor progression [33] , translocation into the nucleus that occurs in response to different apoptotic stimuli [34] , and participation in nuclear transcription complexes in response to hypoxia [35] . Another example of crucial subcellular redistribution is BRCA1, well known for its nuclear-cytoplasmic trafficking in breast cancer [36] ; recently, its redistribution to the cytoplasm in malignant breast cancer tissues has been supposed to be a defence mechanism of the cell probably associated with a more intense cellular apoptotic activity [37] .
However, study of expression and subcellular localization for single proteins or small groups of proteins may often limit understanding of cellular mechanisms because of the complex networking of biological systems. Moreover the high number of moonlighting proteins with different functions in various subcellular compartments as well as massive spatio-temporal and condition-dependent redistribution of proteins makes understanding even more complicated.
Methods for Global Determination of Protein Distributions.
There are a very large number of proposed methods for monitoring protein location within cells. These have been extensively reviewed recently [38] . The vast majority of these methods involve the tagging of proteins with some sort of detectable marker.
This can limit their applicability to global monitoring of dynamic protein distribution, but they may be highly attractive as techniques for confirming results for specific proteins obtained with global methods. We do not consider these methods further here and refer readers to the above review.
At present there seem to be three technologies that are capable of global monitoring. 
Static Studies of the Global Subcellular Distribution of Proteins.
The development of methods for subcellular fractionation to gain more insight into protein function has been emphasized since at least 1946 on the basis of the idea that "The physiology of the cell cannot be fully understood unless we succeed in determining the constitution of its parts..." [43] . The by now large body of work on the proteomes of specific subcellular organelles has often been dominated by the concept that highly pure organelle preparations are required [38] . This focus has carried over to a number of studies of the overall global distribution of proteins to Following the MS analysis, the subcellular localization attributed to functionally interesting proteins can be further confirmed by Western blot analysis ( Figure 3B ).
Many functionally interesting proteins were found to have multiple locations, e.g.
"mitochondrial" proteins (MT-CO2, CYC1, ATP5B, PCK2, SDHA) were observed in both the nucleus and mitochondria, in agreement with the MS results. Overall, 985
proteins were found to be common to mitochondria and the nucleus in MCF7 cells [49] . This is a large number compared to previous studies of highly purified mitochondria/nuclei, which we believe reflects the stripping of important proteins by stringent organelle purification methods, e.g. NRF2 or the hexose kinases (HK1, HK2) from the glycolysis enzymatic cascade that are known to shuttle between mitochondria and nuclei in functional roles that determine the metabolic fate of glucose and are thought to be crucial to cancer metabolism [50].
As noted above collation of results in databases such as GO, LOCATE and iLOC-EUK [38] of large numbers of more conventional cell biology measurements are also consistent with multi-site location of high percentages of cellular proteins.
Monitoring by antibody methods is also converging on this conclusion [51] .
This brings us to the third critical question noted above: (3) how can we reliably identify and verify the functional importance of the dynamic redistribution of such proteins?
Global Dynamics of Subcellular Protein Distribution.
There are by now a number of studies of dynamic changes in the proteome of subcellular organelles using MS-based methods. These were reviewed recently [38] .
Particularly notable have been several studies of expression levels and subcellular localization of endogenous proteins in HeLa cells [52, 53] and viral infections [54]. In the following we limit discussion to several recent SILAC differential labelling studies using a "subcellular spatial razor" approach that are consistent with the conceptual framework outlined above: nucleo-ctyoplasmic trafficking of proteins following engagement of cell cycle checkpoints for DNA replication [55] or exposure to oxidative stress [56] (in human fibroblasts) as well as the response of MCF7 breast cancer cells to estrogen stimulation [57] .
Tandem-mass spectrometry-based shotgun proteomics now allows the rapid, accurate and highly sensitive identification and quantification of several thousand proteins from complex biological samples. The variability caused by pre-MS steps has meant that the development of a reliable method for quantitative analysis is still considered challenging [58] . However, careful attention to the sources of variability can produce data with a high degree of accuracy and reproducibility [46, 49, [55] [56] [57] . Software capable of dealing flexibly and efficiently with quantitative analysis of massive data sets, such as MaxQuant [58, 59] and Perseus, are an essential requirement. In recent studies of the subcellular nucleo-cytoplasmic protein abundance changes for human IMR90 fibroblasts following mild tert-butyl peroxide (TBP) oxidative stress [56] or following cell cycle arrest at the origin activation checkpoint for DNA replication [55] , as well as for MCF7 breast cancer cell following exposure to estrogen (E2)
[57], 12-16 large data sets were processed in parallel with MaxQuant and Perseus.
The processed data for the unfractionated total cell lysate (T), the nucleus- The subcellular spatial razor formulation can distinguish between changes in total protein abundance (St) and redistribution (Sn/Sc) to/from a target organelle (e.g. the nucleus). For all three of the systems so far analyzed with this framework, correlation between changes in total abundance and in subcellular nuclear/cytoplasmic redistribution has been found to be low, i.e. changes in compartmental abundance do not simply mirror changes in total protein abundance [56, 57] . (Fig. 4A) and provides a convenient formulation for visualizing/evaluating the reliability of the compartmental changes [56, 57] . The 3D spatial razor model allows characterization of both total and compartmental changes in protein abundance for each individual protein (Fig. 4B,C) . For instance, the analysis of datasets for estradiol-stimulated (Fig. 4B ) [57] . Similarly, for oxidative stress of IMR90 cells, eight subunits of the CCT protein folding complex showed a substantial C → N redistribution while proliferating cell nuclear antigen (PCNA) showed an opposite N → C redistribution (Fig. 4C) , both with a little or no change in total abundance and suggestive of "catalytic" transfer of information between different subcellular compartments [56] .
An important feature of the subcellular spatial razor formulation is that it is overdetermined and explicitly includes conservation of mass in the quantitative evaluations [56, 57] . This offers new perspectives for checking the selectivity of the detected changes and for evaluation of any effects of "impurity" of the subcellular fractions used in the MS analyses. For example, consistent with the idea that many proteins are dispersed over multiple subcellular locations, the nuclear preparation analysed in the oxidative stress experiments on IMR90 cells contained 371 proteins annotated by GO to mitochondria, only 147 of which were currently also annotated to the nucleus by GO. However, only a small proportion of these "mitochondrial"
proteins showed any change in their fraction in the nucleus in response to oxidative stress ( Fig. 5) and similar changes in a small proportion of the nuclear proteins was observed for those annotated to endoplasmic reticulum, plasma, membrane, the Golgi apparatus, lysosomes, endosomes and peroxisomes [56] . For the other proteins the >2-fold change corresponded to the changes in partitioning of the protein between the nuclear/cytoplasmic compartments, with a strong preponderance of proteins showing N  C redistribution (Fig. 6) . A crucial feature was that >2-fold changes in compartmental abundance were much more prominent than changes in overall abundance. Furthermore, the identities of many of these proteins were consistent with previous studies of estrogen receptors. For example, in the nucleus the ERα and ERβ receptors have been shown to interact with 498 other proteins, only 70 of which are common to both [60] . Of these proteins, 357 were detected in the MCF7 estrogen stimulation experiments: 58 proteins showed >2-fold decrease in nuclear abundance, and a further 76 showed appreciable nucleocytoplasmic redistribution, but none of them showed >2-fold change in total abundance. Of the roughly 1000 proteins that are partitioned between the nucleus and mitochondria, 249 showed evidence of nucleus  cytoplasm redistribution upon exposure to estrogen. For the 134 proteins showing the most significant changes in nucleo-cytoplasmic distribution, investigation of the biological processes in which they are implicated using REACTOME [61, 62] showed association with core cellular processes (gene expression, the cell cycle, protein metabolism, mRNA metabolism) and potential changes in more specific biological processes distributed spatially over the cytoplasm, plasma membrane and nucleus [57] . In short, this work revealed that the dominant response of MCF7 breast cancer cells to estradiol is not changes in the total cellular abundance of proteins, but rather a massive change in their spatial distribution between the nucleus and cytoplasm, with indications that this influences functional processes at many other subcellular spatial locations.
Dynamic Subcellular Distribution of Proteins in Normal and Pathological
Cellular Function.
Evidence of dynamic redistribution of proteins to and from the nucleus/mitochondria/cytoplasm and other subcellular locations following external perturbations such as environmental cues [63] , cell cycle arrest [55, 56] , hormonal stimulation [64] , oxidative stress [65] [66] [67] , or viral infections [68] [69] [70] [71] is increasing rapidly. In a model eukaryotic system, about 50% of a partially characterized yeast proteome (60%) showed dynamic redistribution between the cytosol and different organelles in response to the environmental switches [63] . There is no longer any doubt that dynamic, coordinated, context-dependent redistribution of multitudinous proteins over many subcellular locations is a central mechanism in cellular function.
These recent studies are beginning to characterize the general nature of the involvement of subcellular translocation of proteins in normal cellular function. For example, limited perturbations of healthy cells, including yeast subjected to hypoxia [39] and human fibroblasts subjected to mild oxidative stress [56] or to cell cycle arrest at the origin activation checkpoint for DNA replication [55] , have typically found appreciable changes for 3-5% of proteins. Changes in total cellular abundance and in subcellular spatial redistribution were found to be of about equal importance in producing the spatial partitioning of proteins over compartments that are the basis of cellular response to such stimulations. At the present time, there are indications from studies of viral infection [12, 54, [68] [69] [70] [71] [72] and from the studies of MCF7 breast cancer cells [46, 49, 57] that strong perturbations in basal protein distributions and massive protein redistribution following stimulations may be characteristic of disease.
Attempts to define general features of cancer [23, 24, 73] include uncontrolled proliferation and modified metabolism, especially of metabolism connected with the oxidative state of cells. The latter has been a focus of cancer research ever since
Warburg [74] . The series of experiments on cell cycle arrest at the origin activation checkpoint [55] and response to oxidative [56] in fibroblasts as well as the response of MCF7 cells to estradiol stimulation thus provide a beginning to comparing protein redistribution in important core processes in healthy and cancerous cells. In fact, the series of investigations of cell cycle arrest in IMR90 human fibroblasts [55, 56, 75] were undertaken to investigate the possible use of pharmaceutical modulators of the CDC7-kinase in cancer therapeutics [55, 56, 75, 76] . So far the overall indications are that healthy cells show strongly regulated, coordinated changes in both total abundance and subcellular spatial distribution of relatively small sets of proteins that are highly characteristic of the cellular response to specific stimulations. In contrast, massive changes in subcellular spatial distribution dominated much more limited changes in total abundance for proteins of MCF7 cells subjected to estradiol stimulation. In fact, estrogen receptors themselves undergo subcellular spatial redistribution in many functional contexts and this is known to be connected to core cellular processes, e.g. efflux of ERα from the nucleus is associated with repression of cell cycle progression and S-phase proliferation in MCF7 cells [77] . Estrogen receptors are targeted for proteasomal degradation through a transcription-coupled pathway requiring new protein synthesis [78, 79] and the proteomics experiments also detected major changes in proteasomes that could be coupled to estrogen receptor turnover as well as many other functional processes in both the nucleus and cytoplasm [80] . This led to suggestions that the modified metabolic properties of cancerous MCF7 cells may be mainly based on perturbed spatial distribution of proteins, that this also opens the possibility that transformation and tumorigenicity may also be strongly influenced by perturbed spatial distribution of proteins, and that refocusing on the dominant mechanism for response of breast cancer cells to estradiol may have important consequences for development of therapeutics [57] .
New Challenges for Proteomics and Bioinformatics and Progress Towards
Medical Applications.
The high degree of spatial/functional inhomogeneity of cells and the need for efficient subcellular communication means that the study of dynamic spatial distribution of subcellular proteins is of fundamental importance to improving understanding of cellular processes underlying human diseases. Indeed, this remarkable phenomenon occurs in any kind of cell: roughly half of all subcellular proteins are known to translocate into another compartment to reach their functional location [81] , while most of the ~1,000 different "resident" proteins contained in mitochondria are imported from the cytosol to exert their functional role [82] .
Moreover, numerous mislocalized proteins have been associated with human diseases as diverse as Alzheimer's disease or various types of cancer and aberrant localization of proteins has been shown to contribute to the pathogenesis of many human diseases [83] . The development of reliable quantitative proteomics has many potential applications to clinical settings. In this context, great challenges for oncologists are to ensure the availability of early detection/diagnostic tools and to develop methods for dealing with the enigmatic heterogeneity within the same kind of tumour (intra-tumour heterogeneity). Detection and therapeutic interventions for most cancer types have evolved over the past century, but are still limited to localized forms of cancer and/or advanced stages [84] . Moreover, better detection, targeted therapeutics and monitoring of cancer must be linked to the underlying biological processes associated with the initiation, proliferation, and metastasis stages [84, 85] . Finding ways of rational diagnosis and prognosis is not an easy target and so far often does not take into consideration all the advances in the research platforms, in particular, genomics and proteomics.
It is becoming more apparent that relying on global genomics information is a valuable asset to formulate a hypothesis, identify recognizable tissue signatures, and seek correlations to medical conditions, but the functional states of cells are beyond the scope of genomics alone. The more focussed approach of proteomics is complementary to genomics and can define the functional products (proteins) of the deregulated genes in space and time, which increases our understanding of the underlying biological processes [86, 87] . One of the challenges but also opportunities faced by the comprehensive study of proteomes is that the estimated 20-30,000
human genes can give rise to over one million different proteins with very wide range in orders of magnitude of abundance [88] . 
Five year view:
We expect that in the next several years there will be major improvements in methodology and collection of massive amounts of global data on the dynamics of protein location in cells. We expect that such global analysis will be essential to reliable integration/interpretation of the massive numbers of more conventional investigations of localized features of complex cellular networks. For example, recent global analyses of nuclear cytoplasmic trafficking in the context of oxidative stress [56] and of transcriptional targets of NRF2 [90] suggest new interpretations of the crucial role(s) of NRF2 in oxidative stress responses that are linked to heme/iron homeostasis or to proteins that contain heme/iron as cofactors and that were largely missed by inference from large numbers of conventional experiments [56] . Similarly, results on trafficking in the context of response of MCF7 cells to estrogen have suggested that nuclear hormone receptors may be master integrators of spatial coordination in cells [57] . It is increasingly apparent that spatial coordination is a key aspect of cellular function in both healthy and disease states. We expect that differential network analysis [91] of global features of spatial control will begin to define high level functional processes/networks that are spatially dispersed across many cellular locations. Integration of such information with genomic, transciptomic, and metabolomic information will be crucial to unravelling the enormously complicated complex adaptive systems that cells represent and to exploiting the information in medical and other applications.
Key issues:
1. Analytical methods that can follow dynamic subcellular redistribution of proteins have become available, with a prominent role for MS-based proteomics. (12) , 6080-6101 (2012). ** Provides a wide look at distribution of proteins envolved in oxidative phosphorylation, the tricarboxylic acid cycle, RNA processing/translation, glycolysis and Ras-related signaling traffiking between the nucleus and mitochondria as evidence for spatio-functional integration of these processes over the two different subcellular organelles.
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